| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 7 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $22.78M | - | |
| CEO | 188.2K | $1.83M | - | |
| CFO | 101.4K | $985.1K | - | |
| Other | 99.2K | $963.5K | - | |
| Other | 75.3K | $731.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 17, 2019 | White Barbara | Chief Medical Officer | Buy | 1,389 | $7.20 | $10,000.80 | +0.8% | |
| May 14, 2019 | Millian Craig Stuart | Chief Commercial Officer | Buy | 1,000 | $7.23 | $7,226.60 | +20.0% | |
| May 14, 2019 | Moran Sean F.61 | Chief Financial Officer | Buy | 100 | $7.12 | $712.00 | - | |
| May 13, 2019 | Cohen Yuval65 | Chief Executive Officer | Buy | 995 | $6.99 | $6,954.85 | +1.6% | |
| Mar 15, 2019 | Jenkins John Kenneth | Director | Buy | 1,000 | $6.98 | $6,977.90 | New | |
| Mar 15, 2019 | Hochman David P | Director | Buy | 2,000 | $6.98 | $13,957.60 | +40.0% | |
| Mar 14, 2019 | Millian Craig Stuart | Chief Commercial Officer | Buy | 5,000 | $6.85 | $34,258.50 | New | |
| Mar 14, 2019 | White Barbara | Chief Medical Officer | Buy | 4,638 | $6.47 | $29,993.95 | +2.6% | |
| Mar 14, 2019 | Moran Sean F.61 | Chief Financial Officer | Buy | 1,500 | $6.67 | $10,005.00 | +0.4% | |
| Mar 14, 2019 | Cohen Yuval65 | Chief Executive Officer | Buy | 1,530 | $6.49 | $9,929.70 | +2.5% |